Cutaneous mucormycosis by Rhizopus arrhizus treated with isavuconazole as first line therapy: A case report
Mucormycosis are a group of infections that affect principally immunocompromised host and have a high mortality. Liposomal amphotericin B is the first-line treatment with combined surgical removal of the infectious focus. We report the case of 67-year-old man with idiopathic granulocytic aplasia and...
Main Authors: | G. Zuglian, D. Ripamonti, A. Tebaldi, M. Rizzi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-12-01
|
Series: | Medical Mycology Case Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211753919300740 |
Similar Items
-
Successful treatment of Rhizopus arrhizus rhino-orbital-cerebral mucormycosis with isavuconazole salvage therapy following extensive debridement
by: R.P. Miller, et al.
Published: (2021-06-01) -
Ventriculitis due to infection with Rhizopus arrhizus
by: Stefan Hagel, et al.
Published: (2015-12-01) -
Isavuconazole as salvage therapy for mucormycosis
by: Bianca Graves, et al.
Published: (2016-03-01) -
Successful therapy of progressive rhino-orbital mucormycosis caused by Rhizopus arrhizus with combined and sequential antifungal therapy, surgery and hyperbaric therapy
by: Adrián Imbernón, et al.
Published: (2014-10-01) -
Decolorization of Erythrosine B by Rhizopus arrhizus biomass
by: Neeta A. Salvi
Published: (2018-10-01)